Cite
MLA Citation
Tatjana Terzic et al.. “Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.” Pediatric and developmental pathology, vol. 21, 2018, pp. 355–362. http://access.bl.uk/ark:/81055/vdc_100072459362.0x000018